ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-4.7%
5Y CAGR+1.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-4.7%/yr
vs -5.6%/yr prior
5Y CAGR
+1.5%/yr
Recent deceleration
Acceleration
+1.0pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.79 | +3.1% |
| 2024 | 1.74 | -14.7% |
| 2023 | 2.04 | -1.4% |
| 2022 | 2.07 | -23.0% |
| 2021 | 2.69 | +61.1% |
| 2020 | 1.67 | -52.9% |
| 2019 | 3.54 | +35.6% |
| 2018 | 2.61 | -38.0% |
| 2017 | 4.21 | -22.0% |
| 2016 | 5.39 | - |